Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2)

Free Radic Biol Med. 2003 Jun 15;34(12):1531-43. doi: 10.1016/s0891-5849(03)00152-7.

Abstract

Excessive generation of reactive oxygen species (ROS) in the central nervous system (CNS) is a leading cause of neuronal injury. Despite yet unknown mechanisms, oxidant compounds such as H(2)O(2) have been shown to stimulate the release of arachidonic acid (AA) in a number of cell systems. In this study, H(2)O(2) and menadione, a compound known to release H(2)O(2) intracellularly, were used to examine the phospholipases A(2) (PLA(2)) responsible for AA release from primary murine astrocytes. Both H(2)O(2) and menadione dose-dependently stimulated AA release, and the release mediated by H(2)O(2) was completely inhibited by catalase. H(2)O(2) also stimulated phosphorylation of extracellular signal-regulated kinases (ERK1/2) and cytosolic phospholipase A(2) (cPLA(2)). However, complete inhibition of cPLA(2) phosphorylation by U0126, an inhibitor for mitogen-activated protein kinase kinase (MEK) and GF109203x, a nonselective PKC inhibitor preferring the conventional and novel isoforms, only reduced H(2)O(2)-stimulated AA release by 50%. MAFP, a selective, active, site-directed, irreversible inhibitor of both cPLA(2) and the Ca(2+)-independent iPLA(2), nearly completely inhibited H(2)O(2)-mediated AA release; but, HELSS, a potent irreversible inhibitor of iPLA(2), only inhibited H(2)O(2)-mediated AA release by 40%. Along with the observation that H(2)O(2)-mediated AA release was only partially inhibited upon chelating intracellular Ca(2+) by BAPTA, these results indicate the involvement of both cPLA(2) and iPLA(2) in H(2)O(2)-mediated AA release in murine astrocytes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antifibrinolytic Agents / pharmacology
  • Arachidonic Acid / metabolism*
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Calcium / metabolism
  • Cells, Cultured
  • Cytosol
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Group IV Phospholipases A2
  • Group VI Phospholipases A2
  • Hydrogen Peroxide / pharmacology*
  • MAP Kinase Signaling System
  • Mice
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism
  • Oxidants / pharmacology
  • Phospholipases A / metabolism*
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / pharmacology
  • Vitamin K 3 / pharmacology

Substances

  • Antifibrinolytic Agents
  • Enzyme Inhibitors
  • Oxidants
  • Arachidonic Acid
  • Vitamin K 3
  • Hydrogen Peroxide
  • Protein Kinase C
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Phospholipases A
  • Group IV Phospholipases A2
  • Group VI Phospholipases A2
  • Pla2g6 protein, mouse
  • Calcium